Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-13

Clinical Trial Update: Sublingual Buprenorphine Through Telemedicine vs In-Person Care as Usual [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial from the New York State Psychiatric Institute is comparing sublingual buprenorphine delivered via telemedicine to standard in-person ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • buprenorphine (sublingual) (buprenorphine)

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Opioid Use Disorder | Phase 2 | Status: NOT_YET_RECRUITING